Clinical Trial Update: Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria [NA]

View source ↗

Summary

This clinical trial update evaluates the efficacy and safety of omalizumab for severe acute urticaria. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Urticaria | NA | Status: UNKNOWN